The biologically active form of thyroid hormone, 3,3 ',5-tri-iodothyronine (tri-iodothyronine) , is produced predominantly by enzymic phenolic-ring-or 5'-deiodination of thyroxine in peripheral tissues like the liver and the kidney, whereas the inactive isomer, 3,3',5'-tri-iodothyronine (reverse tri-iodothyronine), is formed by tyrosyl-ring-or 5-deiodination of thyroxine. Both tri-iodothyronines are further degraded by a cascade of deiodinations, with 5'-deiodination to 3,3'-di-iodothyronine as the main initial step in the metabolism of reverse tri-iodothyronine (Visser, 1980) . In a variety of clinical settings a concomitant decrease in tri-iodothyronine production and reverse tri-iodothyronine clearance has been observed, presumably owing to a specific decrease in the 5'-deiodinase activity of the tissues (Braverman & Vagenakis, 1979) . This has led to the hypothesis that the sequential deiodination of thyroxine is catalysed by two distinct enzymes, i.e. an iodothyronine 5-deiodinase and an iodothyronine 5 '-deiodinase (Schimmel & Utiger, 1977; Visser, 1978) . However, subcellular fractionation of rat liver homogenate (Fekkes et al., 1979) and partial purification of detergent extracts of microsomal fractions thereof (Fekkes et al., 1980) , have not resulted in a separation of these two activities.
In the present paper we describe the effect of various inhibitors on the 5-deiodination of triiodothyronine and the 5'-deiodination of 3',5'-diiodothyronine by rat liver microsomal fractions. Evidence is obtained that a single enzyme is responsible for both deiodination reactions in rat liver. Rat liver microsomal fraction was prepared as previously described (Fekkes et al., 1979) . The protein content of this fraction was mesured after solubilization in 0.5 M-NaOH, by a modification of the method of Bradford (1976) , with bovine serum albumin as the standard (Spector, 1978) . Reaction mixtures contained 0.1 M-sodium phosphate/3 mM-EDTA/3 mM-dithiothreitol, pH 7.2, 1-lO,um-triiodothyronine or 0.4-3.2pM-3',5'-di-iodothyronine, 2-4pg of microsomal protein and various inhibitors to be tested, all in a volume of 0.25 ml. The reaction was initiated by addition of microsomal fraction and incubation was carried out for 15 min at 370C. Vol. 20 1 was added after the detergent solution. Each experimental point was determined in duplicate. The amounts of 3,3 '-di-iodothyronine (5-deiodination product of tri-iodothyronine) and 3'-iodothyronine (5'-deiodination product of 3',5'-di-iodothyronine) were measured in duplicate by specific radioimmunoassays in 50,ul of the extract .
Materials and methods

Data analysis
The amount of product formed was corrected for non-enzymic deiodination by subtraction of the respective control value, which was always less than 10% of enzymic deiodination. Regression lines of the double-reciprocal plots were calculated by unweighted least-squares analysis. K1 values for competitive inhibitors were estimated by using the equation:
where Km and Km are-1/intercept on the abscissa in the absence or presence of inhibitor respectively, and III is the concentration of inhibitor.
Results
The enzymic 5-deiodination of tri-iodothyronine was characterized by a mean apparent Km value of 17.4,M, and the 5'-deiodination of 3',5'-di-iodothyronine by a mean apparent Km value of 0.77pM (Table 1) . Tri-iodothyronine was a competitive inhibitor of the 5'-deiodination of 3',5'-di-iodothyronine ( Fig. 1) , with a mean apparent Ki of 19.6,uM (Table 1) . Similarly, 3',5'-di-iodothyronine was a competitive inhibitor of tri-iodothyronine 5-deiodination ( Fig. 2) with a mean apparent K1 of 0.65 AM (Table 1) .
As potential inhibitors of enzymic 5-and 5'-deiodination were tested 3,5-di-iodothyronine, thyronine and the radiographic contrast agents iophenoxic acid, iopanoic acid and tyropanoic acid. All these compounds inhibited both tri-iodothyronine 5-deiodination and 3 ',5 '-di-iodothyronine 5'-deiodination competitively with respect to the substrates (see tyropanoic acid as an example in Figs. 1  and 2 ). Spanning over two orders of magnitude, inhibitor constants of the different compounds were very similar for the two types of deiodination (Table 1) . Among the inhibitors, the 2,4,6-tri-iodophenol derivatives, iophenoxic acid, and the analogous 2,4,6-tri-iodoaniline derivative, iopanoic acid, were the most potent, with apparent Ki value of 1.5-1.9 uM. Thyronine was at least effective, with an apparent Ki of approx. 100,uM.
As a corollary of these findings, Fig. 3 shows the highly significant (r = 0.999) correlation between the mean Km and Ki values for the substrate and competitive inhibitors of tri-iodothyronine 5-deiodination and the corresponding values for 3',5'-di-iodothyronine 5 '-deiodination. A similar relationship (r = 0.996) was observed when we studied the 5 '-deiodination of reverse tri-iodothyronine instead of 3',5'-di-iodothyronine (results not shown).
Discussion
Investigations in vitro involving rat liver preparations have revealed striking similarities between enzymic 5-and 5'-deiodination of iodothyronines.
(1) Both 5-and 5'-deiodinase activities have been localized in the endoplasmic reticulum (Fekkes et al., 1979; Auf dem Brinke et al., 1979 , 1980 .
(2) Both types of deiodination are reductive processes, and are driven by thiols like dithiothreitol . Table 1. inhibited by derivatives of 2-thiouracil , and in both cases this inhibition is uncompetitive with the iodothyronine substrate (Chopra et al., 1978) . Thiouracil is a mechanismbased inhibitor, since it reacts, under formation of a mixed disulphide, with an enzyme-sulphenyl iodide ('E-SI') complex that is an intermediate in the deiodination process (Leonard & Rosenberg, 1978; Visser, 1979) . These findings therefore indicate that 5-and 5'-deiodination follow the same reaction mechanism.
(4) Reaction of rat liver microsomal fractions with 3,5-di-iodothyronine, a substrate of which only the tyrosyl ring can be deiodinated, yields the sulphenyl iodide complex of the enzyme catalysing the phenolic-ring deiodination of other iodothyronines as evidenced by the persistent inactivation of 5'-deiodinase activity in the presence of thiouracil (Visser & Van Overmeeren-Kaptein, 1981) .
(5) lodothyronine 5-and 5'-deiodinase activities in detergent-treated rat liver microsomal fractions have very similar chromatographic and sedimentation properties, although, admittedly, none of the methods used has resulted in a considerable increase in specific enzyme activity (Fekkes et al., 1980 (Brij 56) and cetyl 20 ether (Brij 58)1 extracts of rat liver microsomal fractions. Both before and after removal of phospholipids, 5-and 5'-deiodinase activities were found to co-migrate, indicating identical isoelectric points (Fekkes & Visser, 1981) .
(7) We demonstrate here that rat liver 5-and 5'-deiodinase activities are equally affected by several competitive substances covering a wide range of inhibitory potencies. Furthermore, the Kj value for tri-iodothyronine as a competitive inhibitor of 3',5'-di-iodothyronine 5'-deiodination is equal to its Km value in the 5-deiodination to 3,3'-di-iodothyronine. Conversely, the K, value for 3',5'-di-iodothyronine as a competitive inhibitor of the 5-deiodination of tri-iodothyronine is equal to the apparent Km for 3',5'-di-iodothyronine in its 5'-deiodination to 3 '-iodothyronine.
In conclusion, the present study in conjunction with previously presented findings seriously challenges the generalization of two specific enzymes, i.e. iodothyronine 5-and 5'-deiodinase, being involved in the sequential deiodination of thyroxine in peripheral tissues (Schimmel & Utiger, 1977; Visser, 1978) . Evidence is now compelling that, at least in rat liver, a single enzyme is capable of carrying out both phenolic-and tyrosyl-ring deiodination. If the same holds true for human liver and if this organ plays an important role in the extra-thyroidal conversion of thyroid hormone, then our results imply causes other than changes in deiodinase activity for the regulation of this process.
